Shares of AveXis, Inc. (AVXS) Sees Large Inflow of Net Money Flow

The shares of AveXis, Inc. (AVXS) traded with a loss of -0.08 points or -0.14% in the most recent session. The shares last traded at $55.7. As per the trading info, the shares saw $1.74 million in upticks and lost $0.09 million in downticks, resulting in a net money flow of $1.65 million. The up/down ratio for the day was measured at 19.43. For the week, the shares had posted 1.27%.From the block trade data available, the total upticks were valued at $1.39 million and the total downticks were valued at $0 million, thereby putting the up/down ratio at 0. The net money flow for the block transaction was $1.39 million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.

AveXis, Inc. (NASDAQ:AVXS) rose 2.96% or 1.65 points on Wednesday and made its way into the gainers of the day. After trading began at $56.11 the stock was seen hitting $58.43 as a peak level and $55.15 as the lowest level. The stock ended up at $57.43. The daily volume was measured at 554,089 shares. The 52-week high of the share price is $72.725 and the 52-week low is $16.11. The company has a market cap of $1,589 million.

AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Companys product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant mortality. AveXis, Inc. is headquartered in Bannockburn, Illinois.


Share this post

Leave a Reply